VIVS
Financials
- Market Capitalization 4.31 M
- Employee 11
- Founded 2007
- CEO N/A
- Website www.organovo.com
- Headquarter Delaware, United States
- FIGI BBG001M8GFD0
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4891 |  APUS Apimeds Pharmaceuticals US, Inc. Common Stock | 3.88 USD | -0.51% | -13.78% | -29.07% | +196.18% | 5.86 M USD | ||
| 4899 |  KAPA Kairos Pharma, Ltd. Common Stock | 0.24 USD | 0.00% | 0.00% | -17.24% | -58.62% | 5.69 M USD | ||
| 5018 |  PPCB Propanc Biopharma, Inc. - Common Stock | 1.35 USD | -39.46% | +19.47% | +35.00% | -54.85% | 3.08 M USD | ||
| 5039 |  VBIO Valion Bio, Inc. - Common stock | 0.12 USD | 0.00% | -14.29% | -55.56% | -90.00% | 2.66 M USD |
Frequently asked questions about VivoSim Labs, Inc. Common Stock
What is the VivoSim Labs, Inc. Common Stock stock price today?
The current price of VivoSim Labs, Inc. Common Stock (VIVS) is 0.29. Over the past 24 hours, the stock has changed by 0.00%. Follow the VIVS chart for real-time price dynamics.
What is the stock ticker of VivoSim Labs, Inc. Common Stock?
VivoSim Labs, Inc. Common Stock trades under the ticker VIVS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is VivoSim Labs, Inc. Common Stock stock going up?
VIVS has changed by +3.57% over the last week, -14.71% over the last month, and -84.82% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of VivoSim Labs, Inc. Common Stock?
VivoSim Labs, Inc. Common Stock currently has a market capitalization of 4.31 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were VivoSim Labs, Inc. Common Stock earnings last quarter?
Last quarter, VivoSim Labs, Inc. Common Stock reported earnings of -0.25 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was VivoSim Labs, Inc. Common Stock revenue for the last quarter?
VivoSim Labs, Inc. Common Stock reported quarterly revenue of 18 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was VivoSim Labs, Inc. Common Stock net income for the last quarter?
VivoSim Labs, Inc. Common Stock reported net income of -1.34 M for the last quarter. The previous quarter showed -5.76 M, which means net income changed by +76.79%.
How many employees does VivoSim Labs, Inc. Common Stock have?
As of the latest available data, VivoSim Labs, Inc. Common Stock has 11 employees. Workforce size can provide additional context about the company's scale and operations.
What is VivoSim Labs, Inc. Common Stock EBITDA?
VivoSim Labs, Inc. Common Stock EBITDA is -2.72 M, and its EBITDA margin is -15.11 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy VivoSim Labs, Inc. Common Stock stock?
You can buy VivoSim Labs, Inc. Common Stock (VIVS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in VivoSim Labs, Inc. Common Stock stock?
Investing in VivoSim Labs, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VIVS chart and related analysis on metatrader.com as part of your research.